Utility of an "Allosteric Site-Impaired" M2 Muscarinic Acetylcholine Receptor as a Novel Construct for Validating Mechanisms of Action of Synthetic and Putative Endogenous Allosteric Modulators
Molecular Pharmacology - United States
doi 10.1124/mol.118.112490
Full Text
Open PDFAbstract
Available in full text
Date
September 13, 2018
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)